https://doi.org/10.4081/mem.2003.665
Cloning: the debate in France and the international context.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Authors
In the last January the French Senate - during the intense debate on the revision of the Bioethics Law of 1994 - has approved a law that forbids every form of cloning, both "reproductive" and "therapeutic". It concerns an important, but not yet definitive, result, because it is necessary the approval of the French National Assembly. This result, that deserves to be underlined, is countercurrent in comparison to the general favourable attitude to the "therapeutic" cloning and contrary to "reproductive" one. The French law is lined up with the indications of the European Parliament according to which "a new semantic strategy tries to weaken the moral meaning of the human cloning" since "there is not some difference between therapeutic and reproductive cloning.
In the article the decision of the Senate is inserted in a double context: the biolaw debate in France as well as in the international panorama. The numerous reviewed documents put in evidence that, once more, the human embryo is the centre of the discussion: if the embryo is an object, he can be used for reaching the objectives of the "regenerative" medicine, but if he is a subject he cannot be exploited for any purpose.
The principle of relationship, the principle of equality, the principle of solidarity, the principle of prudence are the indications that the modern conception of the law offers for saying that every human subject is always a juridical subject.
How to Cite
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.
An Open Access Publication is one that meets the following two conditions:
- the author(s) and copyright holder(s) grant(s) to all users a free, irrevocable, worldwide, perpetual right of access to, and a license to copy, use, distribute, transmit and display the work publicly and to make and distribute derivative works, in any digital medium for any responsible purpose, subject to proper attribution of authorship, as well as the right to make small numbers of printed copies for their personal use.
- a complete version of the work and all supplemental materials, including a copy of the permission as stated above, in a suitable standard electronic format is deposited immediately upon initial publication in at least one online repository that is supported by an academic institution, scholarly society, government agency, or other well-established organization that seeks to enable open access, unrestricted distribution, interoperability, and long-term archiving.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.